This paper is in the following e-collection/theme issue:

Formative Evaluation of Digital Health Interventions (1859) Web-based and Mobile Health Interventions (2641) Telehealth and Telemonitoring (1381) Insomnia and Sleep Hygiene (129) Telepsychiatry (136)

Published on in Vol 7 (2023)

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/43738, first published .
Implementing Blended Care to Discontinue Benzodiazepine Receptor Agonist Use for Insomnia: Process Evaluation of a Pragmatic Cluster Randomized Controlled Trial

Implementing Blended Care to Discontinue Benzodiazepine Receptor Agonist Use for Insomnia: Process Evaluation of a Pragmatic Cluster Randomized Controlled Trial

Implementing Blended Care to Discontinue Benzodiazepine Receptor Agonist Use for Insomnia: Process Evaluation of a Pragmatic Cluster Randomized Controlled Trial

Authors of this article:

Kristien Coteur 1 Author Orcid Image ;   Marc Van Nuland 1 Author Orcid Image ;   Birgitte Schoenmakers 1 Author Orcid Image ;   Sibyl Anthierens 2 Author Orcid Image ;   Kris Van den Broeck 2 Author Orcid Image
Article Authors Cited by (3) Tweetations (6) Metrics

Journals

  1. Coteur K, Van Nuland M, Schoenmakers B, Van den Broeck K, Anthierens S. “At the time I only wanted to relieve stress”: Exploring motivation for behaviour change in long-term hypnotic users. Heliyon 2023;9(5):e16215 View
  2. Coteur K, Peters S, Jansen P, Schoenmakers B, Van Nuland M. Reducing long‐term use of benzodiazepine receptor agonists: In‐depth interview study with primary care stakeholders. Health Expectations 2023 View
  3. Soyka M, Wild I, Caulet B, Leontiou C, Lugoboni F, Hajak G. Long-term use of benzodiazepines in chronic insomnia: a European perspective. Frontiers in Psychiatry 2023;14 View